Extending Contingency Management's Benefits With Progressively Increasing Variable Interval Prize Reinforcement

Contingency Management (CM) is highly effective in promoting recovery from substance use disorders, but benefits tend to attenuate over time when CM is discontinued. Identifying modifications of CM delivery that can extend its benefits is an important goal. The goal of this study is to evaluate the use of reinforcements to increase physical activity, specifically walking. The study provides a standard CM intervention to promote walking for three weeks. After three weeks, a progressively increasing variable interval schedule of reinforcement will be evaluated for increasing the durability of effects of the initial CM intervention. We hypothesize that Variable Interval Prize Contingency Management will result in greater adherence to a walking goal of 10,000 steps per day at Week 15 and Week 24 compared to the Control Condition.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Exercise Addictive Behaviors Behavior Behavior, Addictive Compulsive Behavior Impulsive Behavior Motor Activity

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

UConn Heatlh Center

Farmington, Connecticut, 06030-3944, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age > 18 years
currently not physically active
Physically able and willing to walk 10,000 steps per day

Exclusion criteria

psychiatric or physical illness that could interfere with participation

Treatment and study plan

VIP CM

Behavioral

Participants will receive progressively increasing CM for walking 10,000 steps per day over 4 days prior to visit as verified by the pedometer.

Primary outcomes

number of steps walked in seven days prior to follow up assessment, as verified by the pedometer

Time frame: week 15
number of steps walked in seven days prior to follow up assessment, as verified by the pedometer

Time frame: week 24

Sponsors and collaborators

Lead sponsor

UConn Health

Other

Collaborators

National Institute on Drug Abuse (NIDA)

Registry information

Important dates

Study start: 2010
Primary completion: 2012
Study completion: 2012
First posted: Aug 18, 2010
Registry last updated: Apr 9, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed